Clinical trial
Alpha 2 Adrenergic Receptor Agonists for the Prevention of Delirium and Cognitive Decline After Open Heart Surgery (ALPHA2PREVENT): Randomised Controlled Trial.
NCT05029050 is registered in ClinicalTrials.gov with Oslo University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Alpha 2 Adrenergic Receptor Agonists for the Prevention of Delirium and Cognitive Decline After Open Heart Surgery (ALPHA2PREVENT): Randomised Controlled Trial.
- Lead sponsor
- Oslo University Hospital
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- January 17, 2022
- Completion date
- January 31, 2025
- Enrollment
- 900 (estimated)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.